Inside Washington: Safety, Risk, and Biotechnology Regulation

by Jill Wechsler Concerns about product safety and stiffer FDA regulation of manufacturers may be drying up the biotech pipeline

Related Content:

Negotiating and Structuring Strategic Alliances

Finding Funding in Biotechnology: Keeping the Companies Alive

Biotechnology Patent Holders Beware! A Supreme Court Ruling may Significantly Reduce the Value of Your Patent Portfolio